8-K Announcements
6May 5, 2026·SEC
Apr 20, 2026·SEC
Feb 24, 2026·SEC
Westlake Chemical Partners LP (WLKP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Westlake Chemical Partners LP (WLKP) stock price & volume — 10-year historical chart
Westlake Chemical Partners LP (WLKP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Westlake Chemical Partners LP (WLKP) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.40vs $0.43-7.0% | $306Mvs $522M-41.4% |
| Q1 2026 | Feb 24, 2026 | $0.41vs $0.38+8.2% | $323Mvs $313M+3.2% |
| Q4 2025 | Oct 30, 2025 | $0.42vs $0.43-2.3% | $309Mvs $303M+1.9% |
| Q3 2025 | Aug 5, 2025 | $0.41vs $0.44-7.7% | $297Mvs $301M-1.3% |
Westlake Chemical Partners LP (WLKP) competitors in Petrochemicals, plastics and oxygenates — business model, growth, and fundamentals comparison
Westlake Chemical Partners LP (WLKP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Westlake Chemical Partners LP (WLKP) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.17B | 1.29B | 1.09B | 966.67M | 1.21B | 1.59B | 1.19B | 1.14B | 1.17B | 1.23B |
| Revenue Growth % | 18.87% | 9.6% | -15.07% | -11.47% | 25.67% | 31.14% | -25.26% | -4.61% | 2.71% | 13.4% |
| Cost of Goods Sold | 769.31M | 908.46M | 712.44M | 587.79M | 773.15M | 1.22B | 803.33M | 716.96M | 818.85M | 847.22M |
| COGS % of Revenue | 65.59% | 70.66% | 65.25% | 60.81% | 63.64% | 76.31% | 67.46% | 63.12% | 70.19% | - |
| Gross Profit | 403.67M▲ 0% | 377.16M▼ 6.6% | 379.43M▲ 0.6% | 378.88M▼ 0.1% | 441.71M▲ 16.6% | 377.37M▼ 14.6% | 387.46M▲ 2.7% | 418.94M▲ 8.1% | 347.85M▼ 17.0% | 387.53M▲ 0% |
| Gross Margin % | 34.41% | 29.34% | 34.75% | 39.19% | 36.36% | 23.69% | 32.54% | 36.88% | 29.81% | 31.39% |
| Gross Profit Growth % | 3.15% | -6.57% | 0.6% | -0.14% | 16.58% | -14.57% | 2.67% | 8.12% | -16.97% | - |
| Operating Expenses | 29.26M | 27.59M | 29.28M | 25.89M | 31.02M | 29.68M | 29.75M | 28.5M | 28.27M | 27.99M |
| OpEx % of Revenue | 2.49% | 2.15% | 2.68% | 2.68% | 2.55% | 1.86% | 2.5% | 2.51% | 2.42% | - |
| Selling, General & Admin | 29.26M | 27.59M | 29.28M | 25.89M | 31.02M | 29.68M | 29.75M | 28.5M | 28.27M | 27.99M |
| SG&A % of Revenue | 2.49% | 2.15% | 2.68% | 2.68% | 2.55% | 1.86% | 2.5% | 2.51% | 2.42% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 374.41M▲ 0% | 349.57M▼ 6.6% | 350.15M▲ 0.2% | 352.99M▲ 0.8% | 410.69M▲ 16.3% | 347.69M▼ 15.3% | 357.71M▲ 2.9% | 390.44M▲ 9.2% | 319.58M▼ 18.2% | 359.54M▲ 0% |
| Operating Margin % | 31.92% | 27.19% | 32.07% | 36.52% | 33.81% | 21.82% | 30.04% | 34.37% | 27.39% | 29.12% |
| Operating Income Growth % | 2.17% | -6.63% | 0.17% | 0.81% | 16.35% | -15.34% | 2.88% | 9.15% | -18.15% | - |
| EBITDA | 488.39M | 458.41M | 457.47M | 456.14M | 519.5M | 468.76M | 467.91M | 502.34M | 447.56M | 465.71M |
| EBITDA Margin % | 41.64% | 35.66% | 41.9% | 47.19% | 42.76% | 29.42% | 39.29% | 44.22% | 38.36% | 37.72% |
| EBITDA Growth % | 5.11% | -6.14% | -0.21% | -0.29% | 13.89% | -9.77% | -0.18% | 7.36% | -10.91% | 6.92% |
| D&A (Non-Cash Add-back) | 113.98M | 108.84M | 107.32M | 103.15M | 108.81M | 121.07M | 110.2M | 111.9M | 127.98M | 106.17M |
| EBIT | 376.2M | 352.03M | 353.25M | 353.72M | 410.75M | 349.25M | 361.94M | 395.69M | 322.02M | 360.64M |
| Net Interest Income | -21.86M | -21.43M | -19.62M | -12.04M | -8.82M | -13.41M | -26.5M | -25.7M | -22.9M | -40.25M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 21.86M | 21.43M | 19.62M | 12.04M | 8.82M | 13.41M | 26.5M | 25.7M | 22.9M | 35.16M |
| Other Income/Expense | -20.07M | -18.98M | -16.53M | -11.3M | -8.75M | -11.84M | -22.27M | -20.45M | -20.45M | -21M |
| Pretax Income | 354.34M▲ 0% | 330.59M▼ 6.7% | 333.62M▲ 0.9% | 341.68M▲ 2.4% | 401.93M▲ 17.6% | 335.85M▼ 16.4% | 335.44M▼ 0.1% | 369.99M▲ 10.3% | 299.12M▼ 19.2% | 338.54M▲ 0% |
| Pretax Margin % | 30.21% | 25.71% | 30.56% | 35.35% | 33.08% | 21.08% | 28.17% | 32.57% | 25.64% | 27.42% |
| Income Tax | 1.28M | 22K | 728K | 564K | 549K | 1.02M | 813K | 835K | 547K | 617K |
| Effective Tax Rate % | 0.36% | 0.01% | 0.22% | 0.17% | 0.14% | 0.3% | 0.24% | 0.23% | 0.18% | 0.18% |
| Net Income | 48.67M▲ 0% | 49.35M▲ 1.4% | 60.98M▲ 23.6% | 66.17M▲ 8.5% | 82.55M▲ 24.8% | 64.17M▼ 22.3% | 54.28M▼ 15.4% | 62.39M▲ 14.9% | 298.58M▲ 378.5% | 195.12M▲ 0% |
| Net Margin % | 4.15% | 3.84% | 5.58% | 6.84% | 6.79% | 4.03% | 4.56% | 5.49% | 25.59% | 15.8% |
| Net Income Growth % | 18.88% | 1.39% | 23.58% | 8.5% | 24.76% | -22.26% | -15.41% | 14.94% | 378.55% | 271.62% |
| Net Income (Continuing) | 353.06M | 330.57M | 332.89M | 341.12M | 401.38M | 334.83M | 334.63M | 369.16M | 298.58M | 337.92M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 778.93M | 718.27M | 432.05M | 395.17M | 436.15M | 369.21M | 333.74M | 310.61M | 301.24M | 293.72M |
| EPS (Diluted) | 1.72▲ 0% | 1.51▼ 12.2% | 1.77▲ 17.2% | 1.88▲ 6.2% | 2.34▲ 24.5% | 1.82▼ 22.2% | 1.54▼ 15.4% | 1.77▲ 14.9% | 8.47▲ 378.5% | 5.51▲ 0% |
| EPS Growth % | 117.72% | -12.21% | 17.22% | 6.21% | 24.47% | -22.22% | -15.38% | 14.94% | 378.53% | 142.95% |
| EPS (Basic) | 1.72 | 1.53 | 1.77 | 1.88 | 2.34 | 1.82 | 1.54 | 1.77 | 8.47 | - |
| Diluted Shares Outstanding | 28.39M | 32.68M | 34.49M | 35.2M | 35.21M | 35.22M | 35.22M | 35.23M | 35.23M | 35.42M |
| Basic Shares Outstanding | 28.39M | 32.24M | 34.49M | 35.2M | 35.21M | 35.22M | 35.25M | 35.23M | 35.23M | 35.42M |
| Dividend Payout Ratio | 86.54% | 108.14% | 101.81% | 100.3% | 80.41% | 103.49% | 122.36% | 106.48% | 22.26% | - |
Westlake Chemical Partners LP (WLKP) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 231.39M | 247.14M | 238.41M | 263.31M | 281.21M | 245.79M | 226.2M | 240.93M | 143.51M | 148.9M |
| Cash & Short-Term Investments | 27.01M | 19.74M | 19.92M | 17.15M | 17.06M | 64.78M | 58.62M | 58.32M | 44.27M | 44.29M |
| Cash Only | 27.01M | 19.74M | 19.92M | 17.15M | 17.06M | 64.78M | 58.62M | 58.32M | 44.27M | 44.29M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 198.48M | 222.64M | 214.94M | 242.28M | 254.86M | 109.5M | 162.71M | 178.11M | 63.57M | 45.08M |
| Days Sales Outstanding | 61.76 | 63.21 | 71.85 | 91.48 | 76.57 | 25.09 | 49.87 | 57.23 | 19.89 | 23.24 |
| Inventory | 5.59M | 4.39M | 2.48M | 3.47M | 8.9M | 4.71M | 4.43M | 4.06M | 2.77M | 3.09M |
| Days Inventory Outstanding | 2.65 | 1.76 | 1.27 | 2.16 | 4.2 | 1.42 | 2.01 | 2.07 | 1.23 | 1.31 |
| Other Current Assets | 0 | 0 | 1.07M | 392K | 396K | 66.49M | 442K | 444K | 32.9M | 56.44M |
| Total Non-Current Assets | 1.28B | 1.21B | 1.16B | 1.09B | 1.2B | 1.13B | 1.09B | 1.05B | 1.11B | 1.09B |
| Property, Plant & Equipment | 1.2B | 1.15B | 1.1B | 1.05B | 1.04B | 990.21M | 943.84M | 903.59M | 886.01M | 871.61M |
| Fixed Asset Turnover | 0.98x | 1.12x | 0.99x | 0.92x | 1.16x | 1.61x | 1.26x | 1.26x | 1.32x | 1.39x |
| Goodwill | 5.81M | 5.81M | 5.81M | 5.81M | 5.81M | 5.81M | 5.81M | 5.81M | 0 | 5.81M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | -8.03M | -7.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 87.64M | 66.72M | 46.24M | 36.69M | 150.13M | 130.16M | 140.98M | 137.63M | 227.01M | 911.31M |
| Total Assets | 1.52B▲ 0% | 1.46B▼ 3.5% | 1.39B▼ 4.7% | 1.36B▼ 2.7% | 1.48B▲ 9.2% | 1.37B▼ 7.3% | 1.32B▼ 4.0% | 1.29B▼ 2.2% | 1.26B▼ 2.4% | 1.24B▲ 0% |
| Asset Turnover | 0.77x | 0.88x | 0.78x | 0.71x | 0.82x | 1.16x | 0.90x | 0.88x | 0.93x | 0.97x |
| Asset Growth % | -2.57% | -3.51% | -4.7% | -2.65% | 9.16% | -7.34% | -4.02% | -2.19% | -2.44% | -12.65% |
| Total Current Liabilities | 40.24M | 48.77M | 38.85M | 39.75M | 106.8M | 66.94M | 56.34M | 55.37M | 51.3M | 40.79M |
| Accounts Payable | 24.54M | 32.52M | 21.34M | 20.99M | 45.9M | 49.4M | 31.36M | 20.74M | 51.3M | 40.79M |
| Days Payables Outstanding | 11.64 | 13.07 | 10.93 | 13.03 | 21.67 | 14.83 | 14.25 | 10.56 | 22.87 | 16.35 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 14.9M | 12.56M | 60.9M | 2.65M | 5.47M | 17.71M | 0 | 0 |
| Current Ratio | 5.75x | 5.07x | 6.14x | 6.62x | 2.63x | 3.67x | 4.02x | 4.35x | 2.80x | 2.80x |
| Quick Ratio | 5.61x | 4.98x | 6.07x | 6.54x | 2.55x | 3.60x | 3.94x | 4.28x | 2.74x | 2.74x |
| Cash Conversion Cycle | 52.77 | 51.91 | 62.19 | 80.61 | 59.1 | 11.67 | 37.64 | 48.74 | -1.74 | 8.2 |
| Total Non-Current Liabilities | 476.29M | 479.27M | 402.47M | 401.6M | 401.2M | 401.33M | 404.26M | 403.27M | 402.88M | 402.52M |
| Long-Term Debt | 473.96M | 477.61M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.22M | 1.66M | 1.65M | 1.54M | 1.53M | 0 | 1.63M | 1.55M | 0 | 4.62M |
| Other Non-Current Liabilities | 107K | 0 | 1.15M | 381K | 0 | 1.66M | 2.95M | 2.05M | 3.21M | 7.05M |
| Total Liabilities | 516.53M | 528.04M | 441.32M | 441.35M | 508M | 468.27M | 460.59M | 458.64M | 454.18M | 443.31M |
| Total Debt | 473.96M | 477.61M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
| Net Debt | 446.95M | 457.86M | 379.75M | 382.52M | 382.62M | 334.89M | 341.06M | 341.36M | 355.4M | 355.38M |
| Debt / Equity | 0.27x | 0.29x | 0.42x | 0.44x | 0.41x | 0.44x | 0.47x | 0.48x | 0.50x | 0.50x |
| Debt / EBITDA | 0.97x | 1.04x | 0.87x | 0.88x | 0.77x | 0.85x | 0.85x | 0.80x | 0.89x | 0.86x |
| Net Debt / EBITDA | 0.92x | 1.00x | 0.83x | 0.84x | 0.74x | 0.71x | 0.73x | 0.68x | 0.79x | 0.79x |
| Interest Coverage | 17.21x | 16.42x | 18.00x | 29.38x | 46.59x | 26.05x | 13.66x | 15.40x | 14.06x | 10.26x |
| Total Equity | 1.78B▲ 0% | 1.65B▼ 7.1% | 952.13M▼ 42.4% | 915.14M▼ 3.9% | 972.7M▲ 6.3% | 903.71M▼ 7.1% | 856.25M▼ 5.3% | 829.31M▼ 3.1% | 802.35M▼ 3.3% | 792.39M▲ 0% |
| Equity Growth % | 2.2% | -7.05% | -42.38% | -3.89% | 6.29% | -7.09% | -5.25% | -3.15% | -3.25% | -7.95% |
| Book Value per Share | 62.61 | 50.56 | 27.61 | 26.00 | 27.63 | 25.66 | 24.31 | 23.54 | 22.77 | 22.37 |
| Total Shareholders' Equity | 998.75M | 934.08M | 520.09M | 519.97M | 536.55M | 534.5M | 522.51M | 518.7M | 501.11M | 498.66M |
| Common Stock | 461.49M | 458.38M | 520.09M | 519.97M | 536.55M | 534.5M | 522.51M | 518.7M | 501.11M | 498.66M |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 279K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 778.93M | 718.27M | 432.05M | 395.17M | 436.15M | 369.21M | 333.74M | 310.61M | 301.24M | 293.72M |
Westlake Chemical Partners LP (WLKP) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 537.36M | 436.15M | 450.81M | 373.4M | 408.44M | 463.74M | 452M | 485M | 280.47M | 280.47M |
| Operating CF Margin % | 45.81% | 33.93% | 41.29% | 38.63% | 33.62% | 29.11% | 37.96% | 42.7% | 24.04% | - |
| Operating CF Growth % | 86.76% | -18.83% | 3.36% | -17.17% | 9.38% | 13.54% | -2.53% | 7.3% | -42.17% | 22.5% |
| Net Income | 353.06M | 330.57M | 332.89M | 341.12M | 401.38M | 334.83M | 54.28M | 369.16M | 298.58M | 195.12M |
| Depreciation & Amortization | 113.98M | 108.84M | 107.32M | 103.15M | 108.81M | 121.07M | 110.2M | 111.9M | 127.98M | 135.21M |
| Stock-Based Compensation | 289K | 363K | 387K | 375K | 436K | 282K | 349K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | -387K | -375K | -436K | -471.2M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 456.06M | 502.66M | 56K | 731K | 3.92M | 470.92M | 284.9M | 2.16M | 2.74M | 2.63M |
| Working Capital Changes | 70.31M | -3.26M | 10.54M | -71.61M | -105.68M | 7.83M | 2.26M | 1.78M | -148.83M | -130.88M |
| Change in Receivables | 78.51M | 1.03M | 9.29M | -72.93M | -26.29M | -14.44M | 28.66M | 32.96M | -29.55M | -37.6M |
| Change in Inventory | -1.66M | 1.2M | 1.13M | -990K | -5.42M | 4.18M | 283K | 374K | 1.29M | -360K |
| Change in Payables | 1.44M | -4.48M | 421K | 4.25M | 19.78M | -17M | 1.57M | -2.69M | -2.35M | -39.59M |
| Cash from Investing | -203.23M | -51.81M | -57.71M | 2.03M | -64.3M | -12M | -75.94M | -88.97M | 31.18M | -1.42M |
| Capital Expenditures | -68.86M | -39.86M | -43.71M | -36.97M | -81.17M | -54.12M | -46.82M | -48.97M | -78.82M | -68.42M |
| CapEx % of Revenue | 5.87% | 3.1% | 4% | 3.82% | 6.68% | 3.4% | 3.93% | 4.31% | 6.76% | - |
| Acquisitions | 0 | 384M | 529.45M | 349M | 0 | 319.88M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -134.37M | -384M | -529.45M | -349M | -130K | -319.88M | 0 | 0 | 0 | -13M |
| Cash from Financing | -396.02M | -391.6M | -392.92M | -378.2M | -344.24M | -404.01M | -382.23M | -396.33M | -325.7M | -348.8M |
| Debt Issued (Net) | -120.67M | 3.65M | -77.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 110.7M | 0 | 62.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -42.12M | -53.36M | -62.08M | -66.36M | -66.38M | -66.41M | -66.42M | -66.44M | -66.45M | -66.46M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -343.93M | -341.89M | -315.56M | -311.83M | -277.86M | -337.6M | -315.81M | -329.9M | -259.25M | -282.35M |
| Net Change in Cash | -61.89M▲ 0% | -7.26M▲ 88.3% | 179K▲ 102.5% | -2.77M▼ 1646.9% | -97K▲ 96.5% | 47.73M▲ 49301.0% | -6.16M▼ 112.9% | -303K▲ 95.1% | -14.05M▼ 4536.0% | -5.33M▲ 0% |
| Free Cash Flow | 468.5M▲ 0% | 396.29M▼ 15.4% | 407.1M▲ 2.7% | 336.43M▼ 17.4% | 327.27M▼ 2.7% | 409.62M▲ 25.2% | 405.18M▼ 1.1% | 436.03M▲ 7.6% | 201.65M▼ 53.8% | 276.47M▲ 0% |
| FCF Margin % | 39.94% | 30.82% | 37.28% | 34.8% | 26.94% | 25.71% | 34.03% | 38.39% | 17.28% | 22.39% |
| FCF Growth % | 4033% | -15.41% | 2.73% | -17.36% | -2.72% | 25.16% | -1.08% | 7.61% | -53.75% | -25.49% |
| FCF per Share | 16.50 | 12.13 | 11.80 | 9.56 | 9.30 | 11.63 | 11.50 | 12.38 | 5.72 | 5.72 |
| FCF Conversion (FCF/Net Income) | 11.04x | 8.84x | 7.39x | 5.64x | 4.95x | 7.23x | 8.33x | 7.77x | 0.94x | 1.42x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.53M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 831K | 0 | 0 |
Westlake Chemical Partners LP (WLKP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 2.77% | 2.88% | 4.68% | 7.09% | 8.75% | 6.84% | 6.17% | 7.4% | 36.6% | 24.1% |
| Return on Invested Capital (ROIC) | 12.56% | 12.1% | 15.26% | 20.14% | 23.22% | 20.11% | 22.03% | 24.73% | 20.59% | 20.59% |
| Gross Margin | 34.41% | 29.34% | 34.75% | 39.19% | 36.36% | 23.69% | 32.54% | 36.88% | 29.81% | 31.39% |
| Net Margin | 4.15% | 3.84% | 5.58% | 6.84% | 6.79% | 4.03% | 4.56% | 5.49% | 25.59% | 15.8% |
| Debt / Equity | 0.27x | 0.29x | 0.42x | 0.44x | 0.41x | 0.44x | 0.47x | 0.48x | 0.50x | 0.50x |
| Interest Coverage | 17.21x | 16.42x | 18.00x | 29.38x | 46.59x | 26.05x | 13.66x | 15.40x | 14.06x | 10.26x |
| FCF Conversion | 11.04x | 8.84x | 7.39x | 5.64x | 4.95x | 7.23x | 8.33x | 7.77x | 0.94x | 1.42x |
| Revenue Growth | 18.87% | 9.6% | -15.07% | -11.47% | 25.67% | 31.14% | -25.26% | -4.61% | 2.71% | 13.4% |
Westlake Chemical Partners LP (WLKP) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Apr 20, 2026·SEC
Feb 24, 2026·SEC
Westlake Chemical Partners LP (WLKP) stock FAQ — growth, dividends, profitability & financials explained
Westlake Chemical Partners LP (WLKP) reported $1.23B in revenue for fiscal year 2025. This represents a 45% decrease from $2.25B in 2012.
Westlake Chemical Partners LP (WLKP) grew revenue by 2.7% over the past year. Growth has been modest.
Yes, Westlake Chemical Partners LP (WLKP) is profitable, generating $195.1M in net income for fiscal year 2025 (25.6% net margin).
Yes, Westlake Chemical Partners LP (WLKP) pays a dividend with a yield of 8.04%. This makes it attractive for income-focused investors.
Westlake Chemical Partners LP (WLKP) has a return on equity (ROE) of 36.6%. This is excellent, indicating efficient use of shareholder capital.
Westlake Chemical Partners LP (WLKP) generated $276.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Westlake Chemical Partners LP (WLKP) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates